Mary and Ryan Finley donated $3 million to Legacy Health, OHSU to combat COVID-19
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that Mary and Ryan Finley, moved by…
Penn Medicine launched trial to evaluate hydroxychloroquine to treat, prevent COVID-19
On Apr. 3, 2020, a trial led by the Perelman School of Medicine at the University of Pennsylvania…
Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
UW-Madison, FluGen and Bharat Biotech announced development of CoroFlu, a coronavirus vaccine
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies…
Paratek Pharma announced BARDA funding for onshoring the manufacturing supply for NUZYRA (omadacycline)
On Apr. 1, 2020, Innovation Pharma announced BARDA had initiated funding to support the onshoring of Paratek manufacturing…
Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patients
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
Philips to fulfill contract with the HHS for the delivery of 10,000 Trilogy Universal units with accelerated delivery
On Mar. 31, 2020, Philips announced that it was fully committed to fulfill the contract with the U.S….
Cue Health awarded $13 million for rapid, portable, point-of-Care COVID-19 test by BARDA
On Mar. 31, 2020, Cue Health announced that is had been awarded up to $30 million in base…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research
Mayo Clinic in Florida expanded specimen testing and processing capabilities for COVID-19
On Mar. 31, 2020, Mayo Clinic in Florida announced it had significantly ramped up efforts to process and…
Emergent BioSolutions signed agreement with Novavax to manufacture NanoFlu
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent provided molecule-to-market contract development and…
Luminex received BARDA contract to support development of second, rapid SARS-CoV-2 test
On Mar. 31, 2020, Luminex announced it had received $642,450 in funding from the Biomedical Advanced Research and…
Altimmune and the University of Alabama at Birmingham to collaborate on development of single-dose, intranasal COVID-19 vaccine
On Mar. 30, 2020, Altimmune announced that it was launching a collaboration with the University of Alabama at…
Medtronic launched new solutions to help monitor patients for COVID-19
On Mar. 27, 2020, Medtronic announced its Medtronic Care Management Services (MCMS) business had launched two new solutions…
Emory University new site in NIH-sponsored coronavirus vaccine study
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
Amneal Pharmaceuticals donated hydroxychloroquine sulfate to state of Texas
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trial
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
Mayo’s 3D Anatomic Modeling Lab printed model of virus that causes COVID-19
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
$1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary care
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Life Science News | Therapeutics | Vaccine
serum therapy used as possible COVID-19 treatment
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
Novartis commited to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
On Mar. 20, 2020, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine…
Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patients
On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…
Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needs
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
Mayo Clinic developed test to detect COVID-19 infection
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
Cocrystal Pharma announced plans to advance Coronavirus program
On Mar. 6, 2020, Cocrystal Pharma announced it had initiated its Coronavirus program. Cocrystal previously entered into a…
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
New technique helped uncover how Coronaviruses enter cells
On Feb. 24, 2020, researchers at National Institute of Allergy and Infectious Disease’s Rocky Mountain Laboratories in Hamilton,…